Joseph W Eichenbaum
Icahn School of Medicine at Mount Sinai, USA
Jiujiang Zhu
School of Civil Engineering and Architecture, Wuyi University, China
Mervat N Wahba
The University of Tennessee Health Science Center, USA
Jianqing Zhang
The University of China Agricultural, Beijing
Research Article
Published: March 19, 2021
Abstract: The Field Of Gene Therapy Is Growing At A Rapid Pace. The Discovery And Modification Of Adeno-associated Viruses (AAV) As Gene Therapy Vectors Has Allowed For The Development Of Novel Treatments For Neurological And Neuromuscular Disorders. AAV Based Gene Therapy Techniques Can Be Utilized To Add, Replace, Or Modify Genes And Their Expression In Patients, Thus Providing A Potential Beneficial Therapeutic Effect. In Many Cases, Gene Therapy Has The Promising Power To Change The Natural Course Of Debilitating And Fatal Diseases And Give Patients A New Outcome On Life. This Mini Review Will Give A Brief Overview Of The AAV Gene Therapy Field, Highlighting FDA Approved Gene Therapies And Selected Current In-clinic AAV-mediated Therapeutics For Neurological And Neuromuscular Diseases For Which Interim Data Are Available. These Therapies And The Ongoing Clinical Trials Are Currently Laying The Groundwork For Future Gene Therapy Strategies And Clinical Trial Design. Ultimately, They Will Inform The Field On Promises And Limitations That Still Need To Be Overcome.
By Pitra Ariesta Shinta Dewi*
View e-Print
By Dr. Florian Heesch*
View e-Print.jpg)
.jpg)
By Karin Engelhart Jentzsch*
View e-Print
By Traore-Kissima Abdoulaye
View e-Print
By Abdullah A Alabdulgader
View e-Print
By Mohamed Ali Alhosani*
View e-Print.jpg)
By Safa Eldin Abaza*
View e-Print
a Creative Commons Attribution 4.0 International License. Based on a work at www.irispublishers.com.
Best viewed in
| Privacy Policy
